WHO says likely to receive clarifications on Covaxin by weekend

WHO said it expects to receive clarifications from Bharat Biotech by the end of this week on its Covaxin — and will meet on November 3 for a final risk-benefit assessment for Emergency Use Listing

Powered by WPeMatico

Scroll to top